Hemochromatosis;Hemochromatose

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 5 BIS, 2000, Pages

  Moirand, R ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; FERRITIN BLOOD LEVEL; GENETIC ANALYSIS; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; PHENOTYPE; PREVALENCE; ECONOMICS; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METHODOLOGY; MUTATION; PEDIGREE; PHLEBOTOMY; REVIEW;

GENE EXPRESSION; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HUMANS; MUTATION; PEDIGREE; PHENOTYPE; PHLEBOTOMY; POLYMORPHISM, GENETIC;

EID: 0034183689     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Clinical presentation of hemochromatosis: A changing scene
2. Evolving expression of hereditary hemochromatosis
3. Homozygosity for hemochromatosis: Clinical manifestations
4. Long-term survival in patients with hereditary hemochromatosis
5. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases
6. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
7. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
8. Hemochromatosis: Diagnosis and quantification of liver iron with gradient-echo MR imaging
9. Hemochromatose genetique, arthropathies et fonction parathyroidienne
10. The arthropathy of hemochromatosis. Recent studies
11. L'arthropathie de l'hemochromatose: Manifestation souvent inaugurale de la maladie
12. Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis
13. Osteoporosis in hemochromatosis: Iron excess, gonadal deficiency, or other factors ?
14. Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis
15. Cardiac abnormalities in primary hemochromatosis
16. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
17. Abces hepatiques a Yersinia enterocolitica d'evolution spontanement favorable
18. Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients
19. Hepatitis C virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda (PCT)
20. Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods
21. Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations
22. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: A study of 185 patients
23. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis
24. Phenotypic expression of the HFE mutations: A French study of 1110 unrelated iron-overloaded patients and relatives
25. Liver fibrosis in genetic hemochromatosis Respective roles of iron and non-iron-related factors in 127 homozygous patients
26. Genetic hemochromatosis in women: Clinical features in 176 women compared to men
27. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
28. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention
29. Long-term survival analysis in hereditary hemochromatosis
30. The effect of arthritis on the quality of life in hereditary hemochromatosis
31. Global prevalence of putative haemochromatosis mutations
32. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal
33. The hemochromatosis 845 G→A and 187 C→G mutations: Prevalence in non-Caucasian populations
34. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis
35. A genotypic study of 217 unrelated probands diagnosed as << genetic hemochromatosis >> on << classical >> phenotypic criteria
36. Haemochromatosis and HLA-H
37. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation
38. Heterogeneity of hemochromatosis in Italy
39. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
40. The significance of the 187G (H63D) mutation in hemochromatosis
41. H63D is an haemochromatosis associated allele
42. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus
43. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans
44. Non-C282Y familial iron overload: Evidence for locus heterogeneity in haemochromatosis
45. Severe juvenile haemochromatosis (JH) missing fiFE gene variants: Implications for a second gene locus leading to iron overload
46. Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder
47. Juvenile and adult hemochromatosis are distinct genetic disorders
48. HLA-H and associated proteins in patients with hemochromatosis
49. Polymorphism in the HFE gene
50. The effect of HFE mutations on serum ferdtin and transferrin saturation in the Jersey population
51. Impact of HLA-H mutations on iron stores in healthy elderly men and women
52. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency?
53. The significance of haemochromatosis gene mutations in the general population: Implications for screening
54. Cardiac hemochromatosis: Beneficial effects of iron removal therapy. An echocardiographic study
55. Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis
56. The principles and practice of screening for disease
57. Faut il depister l'hemochromatose? Une analyse critique de la litterature
58. Neonatal screening for the hemochromatosis defect
59. Genetic discrimination and screening for hemochromatosis
60. L'hemochromatose heterozygote a l'heure du gene HFE (resume)
61. Screening for hemochromatosis in children of homozygotes: Prevalence and cost-effectiveness
62. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis
63. Prevalence of idiopathic hemochromatosis in Italy: Study of 1301 blood donors
64. Screening for haemochromatosis: Prevalence among Danish blood donors
65. Prevalence of hemochromatosis among 11065 presumably healthy blood donors
66. Prevalence of hereditary haemochromatosis in two Swedish urban areas
67. Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients
68. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older
69. Prevalence of haemochromatosis amongst asymptomatic Australians
70. Usefulness of biochemical screening of diabetic patients for hemochromatosis
71. Iron deficiency and iron overload in Swedish male adolescents
72. Population screening for haemochromatosis: Expectations based on a study of relatives of symptomatic probands
73. Cost-effectiveness analysis for evaluation of screening programs: Hereditary hemochromatosis
74. Cost-effectiveness of screening for hereditary hemochromatosis
75. Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database
76. Mutations in the MHC class-I like candidate gene for hemochromatosis in French patients
77. Phenotype-genotype correlation in haemochromatosis subjects
78. A simple genetic test identifies 90 % of UK patients with haemochromatosis
79. Correlation between genotype and phenotype in hereditary hemochromatosis: Analysis of 61 cases
80. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis
81. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in Eastern England
82. Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis
83. A Candidate gene for hemochromatosis: Frequence of the C282Y and H63D mutations
84. Haemochromatosis and HLA-H
85. HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis
86. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients
87. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
88. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls
89. Mutation analysis of the HLA-H gene in French hemochromatosis patients, and genetic counselling in families
90. High incidence of the Cys 282 Tyr mutation in the lIFE gene in the Irish population. Implications for haemochromatosis
91. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany
92. HFE mutations in patients with hereditary haemochromatosis in Sweden
93. Hemochromatosis in Ireland and HFE
94. Prevalence of the C282Y mutation in Brittany: Penetrance of genetic hemochromatosis?
95. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations
96. Allele frequencies of hereditary hemochromatosis gene mutations in a local population of West Brittany
97. Frequency of the HFE C282Y and H63D mutations in distinct ethnic groups living in Spain
98. High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation
99. Hereditary haemochromatosis mutation frequencies in the general population
100. HLA-H mutations in the Ashkenazi Jewish population